3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
12
Endocrine
1
Conditions
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Neuroendocrine Tumors
1
Meningioma
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
3
entrectinib
2
Radiotherapy
2
Proton Therapy
2
Fluorodeoxyglucose F18
2
FAPI-46
2
tipifarnib
1
pegvisomant
1
fluorodopa F 18
1
entinostat
1
dactolisib
1
alectinib
1
Trastuzumab
1
Tamoxifen
1
Surveys and Questionnaires
1
Specimen Handling
1
Ritonavir
1
Respiratory Therapy
1
Radiation Dose Hypofractionation
1
Quality of Life
1
Protons
1
Positron-Emission Tomography
1
Photochemotherapy
1
Patient Reported Outcome Measures
1
Octreotide
1
Neuropsychological Tests
1
Molecular Diagnostic Techniques
1
Indinavir
1
Immunotherapy
1
Furosemide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Neuropsychological Tests
×
Endocrine
×
Clear all
NCT05727605
2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
120 enrolled